Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia

Journal of Rheumatology

Volumn 30, Issue 3, 2003, Pages 628-629

  Margolin, Leon ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE   (Israel)

Author keywords

Eosinophilia myalgia syndrome; Hypoalbuminemia; Hypoproteinemia; L tryptophan

Indexed keywords

PREDNISONE; TRYPTOPHAN;

ADULT; ANAMNESIS; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; EOSINOPHILIA MYALGIA SYNDROME; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; HYPOPROTEINEMIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUVA; SKIN BIOPSY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; EDEMA; EOSINOPHILIA-MYALGIA SYNDROME; FEMALE; HUMANS; HYPOALBUMINEMIA; MIDDLE AGED; PREDNISONE; TRYPTOPHAN;

EID: 0037333919     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Sullivan EA, Staehling N, Philen RM. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases. J Rheumatol 1996;23:1784-7.
2. Sternberg EM. Pathogenesis of L-tryptophan eosinophilia myalgia syndrome. Adv Exp Med Biol 1996;398:325-30.
3. Centers for Disease Control and Prevention. Eosinophilia myalgia syndrome - New Mexico. MMWR Morb Mortal Wkly Rep 1989;38:765-7.
4. Centers for Disease Control and Prevention. Eosinophilia myalgia syndrome and L-tryptophan-containing products - New Mexico, Minnesota, Oregon, and New York. MMWR Morb Mortal Wkly Rep 1989;38:785-8.
5. Hertzman PA. Criteria for the definition of the eosinophilia-myalgia syndrome. J Rheumatol 1996;23 Suppl 46:7-12.